AstraZeneca details ‘very ambitious’ strategy for early-stage obesity programs

AstraZeneca plans to develop treatment options for people with different BMIs as part of its “very ambitious” obesity strategy.

AstraZeneca CEO Pascal Soriot on Thursday …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

How expanded methadone access helped Switzerland defuse its drug crisis

You’re reading Part 4 of The War on Recovery, a yearlong investigation into how the U.S. denies lifesaving medications to people with opioid addiction. Read

March 26, 2024

Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking – Psychedelic Alpha

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already

July 16, 2024

Sutro strengthens its immuno-oncology pipeline with two new ADCs – Pharmaceutical Technology

Sutro generated $772m in partnership payments as of 30 June 2023. Image Credit: Plufflyman / Shutterstock. Sutro Biopharma plans to submit investigational new drug (IND)

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.